Retention of brivaracetam in adults with drug-resistant epilepsy at a single tertiary care center
Open Access
- 16 August 2022
- journal article
- research article
- Published by Elsevier in Epilepsy & Behavior
- Vol. 135, 108868
Abstract
No abstract availableKeywords
Funding Information
- UCLH Biomedical Research Centre
- UCB
- Epilepsy Society
- National Institute for Health and Care Research
- University College London
This publication has 36 references indexed in Scilit:
- Long term retention of retigabine in a cohort of people with drug resistant epilepsySeizure: European Journal of Epilepsy, 2014
- Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase III randomized, double‐blind, placebo‐controlled trialEpilepsia, 2013
- Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: Results from a double‐blind, randomized, placebo‐controlled trialEpilepsia, 2013
- Long-term retention of lacosamide in a large cohort of people with medically refractory epilepsy: A single centre evaluationEpilepsy Research, 2013
- The long-term retention of pregabalin in a large cohort of patients with epilepsy at a tertiary referral centreEpilepsy Research, 2009
- Quality-of-life trajectories in epilepsy: A review of the literatureEpilepsy & Behavior, 2008
- Long-term retention rates of new antiepileptic drugs in adults with chronic epilepsy and learning disabilityEpilepsy & Behavior, 2007
- Clinical Pharmacokinetics of OxcarbazepineClinical Pharmacokinetics, 2003
- The Long‐Term Use of Gabapentin, Lamotrigine, and Vigabatrin in Patients with Chronic EpilepsyEpilepsia, 1999
- Clinical Pharmacokinetics of CarbamazepineClinical Pharmacokinetics, 1978